134 related articles for article (PubMed ID: 2167917)
21. Immunohistochemical demonstration of fluoropyrimidine-metabolizing enzymes in various types of cancer.
Kamoshida S; Shiogama K; Shimomura R; Inada K; Sakurai Y; Ochiai M; Matuoka H; Maeda K; Tsutsumi Y
Oncol Rep; 2005 Nov; 14(5):1223-30. PubMed ID: 16211289
[TBL] [Abstract][Full Text] [Related]
22. Activity and substrate specificity of pyrimidine phosphorylases and their role in fluoropyrimidine sensitivity in colon cancer cell lines.
Temmink OH; de Bruin M; Turksma AW; Cricca S; Laan AC; Peters GJ
Int J Biochem Cell Biol; 2007; 39(3):565-75. PubMed ID: 17098463
[TBL] [Abstract][Full Text] [Related]
23. Thymidine phosphorylase activity in human bladder cancer: difference between superficial and invasive cancer.
Kubota Y; Miura T; Moriyama M; Noguchi S; Matsuzaki J; Takebayashi S; Hosaka M
Clin Cancer Res; 1997 Jun; 3(6):973-6. PubMed ID: 9815773
[TBL] [Abstract][Full Text] [Related]
24. Specificity of pyrimidine nucleoside phosphorylases and the phosphorolysis of 5-fluoro-2'-deoxyuridine.
Woodman PW; Sarrif AM; Heidelberger C
Cancer Res; 1980 Mar; 40(3):507-11. PubMed ID: 6451286
[TBL] [Abstract][Full Text] [Related]
25. [5'-Deoxy-5-fluorouridine enzymatic activation from the masked compound to 5-fluorouracil in human malignant tissues].
Hara Y
Gan To Kagaku Ryoho; 1984 Oct; 11(10):2133-43. PubMed ID: 6237613
[TBL] [Abstract][Full Text] [Related]
26. Uridine kinase, adenylate kinase, and guanase in human lung tumors.
Greengard O; Head JF; Goldberg SL
Cancer Res; 1980 Jul; 40(7):2295-9. PubMed ID: 6248202
[TBL] [Abstract][Full Text] [Related]
27. Uridine phosphorylase (-/-) murine embryonic stem cells clarify the key role of this enzyme in the regulation of the pyrimidine salvage pathway and in the activation of fluoropyrimidines.
Cao D; Russell RL; Zhang D; Leffert JJ; Pizzorno G
Cancer Res; 2002 Apr; 62(8):2313-7. PubMed ID: 11956089
[TBL] [Abstract][Full Text] [Related]
28. [Analysis of the salvage synthesis within biosynthesis of nucleic acid route in colon cancer].
Katsumata K; Sumi T; Murohashi T; Nagashima K; Uda O; Ashizawa T; Yamamoto K; Koyanagi Y
Gan To Kagaku Ryoho; 2000 Aug; 27(9):1415-20. PubMed ID: 10969598
[TBL] [Abstract][Full Text] [Related]
29. Ribose-1-P is the essential precursor for nucleic acid synthesis in animal cells growing on uridine in the absence of sugar.
Wice BM; Kennell D
J Biol Chem; 1982 Mar; 257(5):2578-83. PubMed ID: 6277907
[No Abstract] [Full Text] [Related]
30. [Estimation of pathways of 5-fluorouracil anabolism in human cancer cells in vitro and in vivo].
Fukushima M; Nomura H; Murakami Y; Shirasaka T; Aiba K
Gan To Kagaku Ryoho; 1996 May; 23(6):721-31. PubMed ID: 8645024
[TBL] [Abstract][Full Text] [Related]
31. [Mode of action of fluoropyrimidines, in relation to their clinical application].
Suga S; Kimura K; Kubo K; Aoyama H; Inukai N; Kato K; Horiuchi T; Sawada H; Yokoyama Y
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2301-6. PubMed ID: 6497396
[TBL] [Abstract][Full Text] [Related]
32. Pyrimidine metabolism in Tritrichomonas foetus.
Jarroll EL; Lindmark DG; Paolella P
J Parasitol; 1983 Oct; 69(5):846-9. PubMed ID: 6200591
[TBL] [Abstract][Full Text] [Related]
33. Metabolic effects of novel N-1-sulfonylpyrimidine derivatives on human colon carcinoma cells.
Glavas-Obrovac L; Karner I; Stefanić M; Kasnar-Samprec J; Zinić B
Farmaco; 2005; 60(6-7):479-83. PubMed ID: 15913614
[TBL] [Abstract][Full Text] [Related]
34. Alterations in differentiation and pyrimidine pathway enzymes in 5-azacytidine resistant variants of a myoblast line.
Ng SK; Rogers J; Sanwal BD
J Cell Physiol; 1977 Feb; 90(2):361-47. PubMed ID: 65357
[TBL] [Abstract][Full Text] [Related]
35. [Effect of chemotherapy on the nucleoside phosphate kinase activity in experimental tumors].
Tret'iakov AV; Filov VA
Vopr Onkol; 1986; 32(11):95-8. PubMed ID: 3024413
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biologic study of IV-14, a new ribonucleoside radiotracer for tumor visualization.
Zlatopolskiy BD; Morgenroth A; Kunkel FH; Urusova EA; Dinger C; Kull T; Lepping C; Reske SN
J Nucl Med; 2009 Nov; 50(11):1895-903. PubMed ID: 19837748
[TBL] [Abstract][Full Text] [Related]
37. Multiple regulation of nucleoside catabolizing enzymes: regulation of the deo operon by the cytR and deoR gene products.
Hammer-Jespersen K; Munch-Ptersen A
Mol Gen Genet; 1975; 137(4):327-35. PubMed ID: 171553
[TBL] [Abstract][Full Text] [Related]
38. Regulation of enzymes by ligand induced change in polymerization.
Traut TW; Cheng N; Matthews MM
Adv Exp Med Biol; 1986; 195 Pt B():249-54. PubMed ID: 3020906
[No Abstract] [Full Text] [Related]
39. Enzymology of pyrimidine and carbohydrate metabolism in human colon carcinomas.
Denton JE; Lui MS; Aoki T; Sebolt J; Takeda E; Eble JN; Glover JL; Weber G
Cancer Res; 1982 Mar; 42(3):1176-83. PubMed ID: 7059974
[No Abstract] [Full Text] [Related]
40. Uridine kinase: altered subunit size or enzyme expression as a function of cell type, growth stimulation, or mutagenesis.
Cheng N; Traut TW
J Cell Biochem; 1987 Nov; 35(3):217-29. PubMed ID: 2826505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
